Jentadueto XR 5 mg/1

Jentadueto XR 5 mg/1 combines linagliptin and metformin hydrochloride for extended-release blood sugar management. This oral medication supports glucose control in adults with type 2 diabetes.

Jentadueto XR 5 mg/1 is used to manage blood sugar levels in adults with type 2 diabetes. It combines two active ingredients: linagliptin, a DPP-4 inhibitor, and metformin hydrochloride, a biguanide. This combination helps regulate glucose levels by improving insulin sensitivity and reducing glucose production in the liver. People often ask, 'What is Jentadueto XR used for?' It is typically prescribed as part of a broader diabetes management plan, which may include diet and exercise.

Common effects of Jentadueto XR 5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience headache or dizziness. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Jentadueto XR 5 mg/1 should be handled with care, especially for those with kidney issues or a history of lactic acidosis. It is important to stay hydrated and avoid excessive alcohol consumption while taking this medication. Always follow the advice of a healthcare professional regarding the use of Jentadueto XR.

Jentadueto XR 5 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol can also affect how this medication works and should be avoided. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.